Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries

BMC Bioinformatics

Volumn 17, Issue 1, 2016, Pages

  Atal, Ignacio ^a,b,c   Zeitoun, Jean David ^a,b,c   Névéol, Aurélie ^d   Ravaud, Philippe ^a,b,c,e   Porcher, Raphaël ^a,b,c   Trinquart, Ludovic ^a,b,e  

^a HÔTEL DIEU   (France)

^b PARIS DESCARTES UNIVERSITY   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e Department of Epidemiology ^*  (United States)

Author keywords

Clinical trials; Disease classification; Global burden of diseases; Mapping

Indexed keywords

CLINICAL RESEARCH; HEURISTIC ALGORITHMS; KNOWLEDGE BASED SYSTEMS; MAPPING; MEDICAL APPLICATIONS; NATURAL LANGUAGE PROCESSING SYSTEMS; TAXONOMIES; TERMINOLOGY; TUMORS;

AUTOMATIC CLASSIFICATION; CLINICAL TRIAL; DISEASE CLASSIFICATION; KNOWLEDGE SOURCES; MANUAL CLASSIFICATION; MEDICAL TERMINOLOGIES; RESEARCH COMMUNITIES; UNIFIED MEDICAL LANGUAGE SYSTEMS;

CLASSIFIERS;

EID: 84995595318     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/s12859-016-1247-7     Document Type: Article

References (51)

1. Adam T, Røttingen J-A, Kieny M-P. Informing the establishment of the WHO Global Observatory on Health Research and Development: a call for papers. Heal Res Policy Syst. 2015;13:9.
2. Røttingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Ardal C, Guzman J, Edwards D, Matlin SA, Terry RF. Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory? Lancet. 2013;382:1286-307.
3. Terry RF, Salm JF, Nannei C, Dye C. Creating a global observatory for health R&D. Science. 2014;345:1302-4.
4. Ahmad N, Boutron I, Dechartres A, Durieux P, Ravaud P. Geographical representativeness of published and ongoing randomized controlled trials. the example of: Tobacco consumption and HIV infection. PLoS ONE. 2011;6:e16878.
5. Global Observatory on Health R&D [http://www.who.int/research-observatory/en/]
6. Atal I, Trinquart L, Porcher R, Ravaud P. Differential globalization of industry- and non-industry-sponsored clinical trials. PLoS ONE. 2015;10:e0145122.
7. Viergever RF, Karam G, Reis A, Ghersi D. The quality of registration of clinical trials: still a problem. PLoS ONE. 2014;9:e84727.
8. International Clinical Trials Registry Platform [http://www.who.int/ictrp/glossary/en/]. Accessed 1 Feb2014.
9. Viergever RF, Li K. Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013. BMJ Open. 2015;5:e008932.
10. Demner-Fushman D, Chapman WW, McDonald CJ. What can natural language processing do for clinical decision support? J Biomed Inform. 2009;42(5):760-72.
11. Névéol A, Zweigenbaum P. Clinical natural language processing in 2014: foundational methods supporting efficient healthcare. Yearb Med Inf. 2014;2015(10):194-8.
12. McCray AT, Tse T. Understanding search failures in consumer health information systems. AMIA Annu Symp Proc 2003:430-4.
13. ClinicalTrials.gov [http://clinicaltrials.gov/]
14. Weng C, Tu SW, Sim I, Richesson R. Formal representation of eligibility criteria: A literature review. J Biomed Inform. 2010;43(3):451-67.
15. Besana P, Cuggia M, Zekri O, Bourde A, Burgun A. Using Semantic Web technologies for Clinical Trial Recruitment. In: The Semantic Web - ISWC 2010. Berlin Heidelberg: Springer; 2010. p. 34-49.
16. Milian K, Bucur A, Van Harmelen F. Building a library of eligibility criteria to support design of clinical trials. Knowl Eng Knowl Manag Lect Notes Comput Sci. 2012;7603:327-36.
17. Huang Z, ten Teije A, van Harmelen F: SemanticCT. A Semantically-Enabled System for Clinical Trials. Process Support and Knowledge Representation in Health Care. Murcia: Springer International Publishing; 2013.
18. Luo Z, Miotto R, Weng C. A human-computer collaborative approach to identifying common data elements in clinical trial eligibility criteria. J Biomed Inform. 2013;46:33-9.
19. Hao T, Rusanov A, Boland MR, Weng C. Clustering clinical trials with similar eligibility criteria features. J Biomed Inform. 2014;52:112-20.
20. He Z, Carini S, Hao T, Sim I, Weng C. A method for analyzing commonalities in clinical trial target populations. AMIA Annu Symp Proc. 2014;2014:1777-86.
21. He Z, Carini S, Sim I, Weng C. Visual aggregate analysis of eligibility features of clinical trials. J Biomed Inf. 2015;54:241-55.
22. Korkontzelos I, Mu T, Ananiadou S. ASCOT: a text mining-based web-service for efficient search and assisted creation of clinical trials. BMC Med Inform Decis Mak. 2012;12 Suppl 1:S3.
23. Boland MR, Miotto R, Gao J, Weng C. Feasibility of feature-based indexing, clustering, and search of clinical trials. Methods Inf Med. 2013;52:382-94.
24. Boland MR, Weng C. A method for probing disease relatedness using common clinical eligibility criteria. Stud Health Technol Inform. 2013;192:481-5.
25. Miotto R, Jiang S, Weng C. ETACTS: A method for dynamically filtering clinical trial search results. J Biomed Inform. 2013;46:1060-7.
26. Weng C, Wu X, Luo Z, Boland MR, Theodoratos D, Johnson SB. EliXR: an approach to eligibility criteria extraction and representation. J Am Med Inform Assoc. 2011;18:i116-24.
27. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin AA, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-128.
28. Murray CJL, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, Wikler D, Lopez AD. GBD 2010: Design, definitions, and metrics. Lancet. 2012;380:2063-6.
29. Ide NC, Loane RF, Demner-Fushman D. Essie: A concept-based search engine for structured biomedical text. J Am Med Informatics Assoc. 2007;14:253-63.
30. Tasneem A, Aberle L, Ananth H, Chakraborty S, Chiswell K, McCourt BJ, Pietrobon R. The database for aggregate analysis of clinicaltrials.gov (AACT) and subsequent regrouping by clinical specialty. PLoS ONE. 2012;7:e33677.
31. International statistical classification of diseases and related health problems. -10th revision [http://www.who.int/classifications/icd/en]
32. Bodenreider O. The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004;32(Database issue):D267-70.
33. Aronson AR, Lang F-M. An overview of MetaMap: historical perspective and recent advances. J Am Med Informatics Assoc. 2010;17:229-36.
34. Fung KW, Bodenreider O. Utilizing the UMLS for semantic mapping between terminologies. AMIA Annu Symp Proc 2005:266-270.
35. Emdin CA, Odutayo A, Hsiao AJ, Shakir M, Hopewell S, Rahimi K, Altman DG. Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials - ESORT). BMJ. 2015;350:h117.
36. Viergever RF, Terry RF, Karam G. Use of data from registered clinical trials to identify gaps in health research and development. Bull World Heal Organ. 2013;91(6):416-425C.
37. World Health Organization. The Global Burden of Disease: 2004 Update. 2008
38. Bourgeois FT, Olson KL, Ioannidis JP A, Mandl KD. Association between pediatric clinical trials and global burden of disease. Pediatrics. 2014;133:78-87.
39. Isaakidis P, Swingler GH, Pienaar E, Volmink J, Ioannidis JP. Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research. BMJ. 2002;324:702.
40. Swingler GH, Volmink J, Ioannidis JP. Number of published systematic reviews and global burden of disease: database analysis. BMJ. 2003;327:1083-4.
41. Karimkhani C, Boyers LN, Prescott L, Welch V, Delamere FM, Nasser M, Zaveri A, Hay RJ, Vos T, Murray CJL, Margolis DJ, Hilton J, Maclehose H, Williams HC, Dellavalle RP. Global burden of skin disease as reflected in cochrane database of systematic reviews. JAMA Dermatol. 2014;150:945-51.
42. Perel P, Miranda JJ, Ortiz Z, Casas JP. Relation between the global burden of disease and randomized clinical trials conducted in latin America published in the five leading medical journals. PLoS ONE. 2008;3:e1696.
43. Cottingham MD, Kalbaugh CA, Fisher JA. Tracking the pharmaceutical pipeline: clinical trials and global disease burden. Clin Transl Sci. 2014;7:297-9.
44. Mork JG, Yepes AJJ, Aronson AR. The NLM Medical Text Indexer System for Indexing Biomedical Literature. In BioASQ@ CLEF; 2013
45. Aronson AR, Bodenreider O, Demner-Fushman D, Fung KW, Lee VK, Mork JG, Névéol A, Peters L, Rogers WJ. From indexing the biomedical literature to coding clinical text: experience with MTI and machine learning approaches. Proc Work BioNLP 2007 Biol Transl Clin Lang Process 2007;105-12.
46. Evans JA, Shim J-M, Ioannidis JP. Attention to local health burden and the global disparity of health research. PLoS ONE. 2014;9:e90147.
47. World Health Organization. International Standards for Clinical Trial Registries. 2012.
48. Ruiz ME, Aronson A. User-Centered Evaluation of the Medical Text Indexing (MTI) System - Technical Report - US National Library of Medicine. 2007
49. Luo Y, Xin Y, Hochberg E, Joshi R, Uzuner O, Szolovits P. Subgraph augmented non-negative tensor factorization (SANTF) for modeling clinical narrative text. J Am Med Informatics Assoc. 2015;22:1009-19.
50. Pradhan S, Elhadad N, South BR, Martinez D, Christensen L, Vogel A, Suominen H, Chapman WW, Savova G. Evaluating the state of the art in disorder recognition and normalization of the clinical narrative. J Am Med Inform Assoc. 2015;22:143-54.
51. NIH-NLM. SNOMED Clinical Terms® (SNOMED CT®). NIH-US National LIbrary of Medicine 2015.